Abstract:It is a great challenge to isolate the broadly neutralizing antibodies (bnAbs) against foot-and-mouth disease virus (FMDV) due to its existence as seven distinct serotypes without cross-protection. Here, by vaccination of pig with FMDV serotype O and A whole virus antigens, we obtained 10 bnAbs against serotypes O, A and/or Asia1 by dissecting 216 common clonotypes of two serotype O and A specific porcine B-cell receptor (BCR) gene repertoires containing total 12720 B cell clones, indicating the induction of cross-serotype bnAbs after sequential vaccination with serotypes O and A antigens. The majority of porcine bnAbs (9/10) were derived from terminally differentiated B cells of different clonal lineages, which convergently targeted the conserved "RGDL" motif on structural protein VP1 of FMDV by mimicking receptor recognition to inhibit viral attachment to cells. Cryo-EM complex structures revealed that the other bnAb pOA-2 specifically targets a novel inter-pentamer antigen structure surrounding the viral three-fold axis, with a highly conserved determinant at residue 68 on VP2. This unique binding pattern enabled cross-serotype neutralization by destabilizing the viral particle. The evolutionary analysis of pOA-2 demonstrated its origin from an intermediate B-cell, emphasizing the crucial role of somatic hypermutations (SHMs) in balancing the breadth and potency of neutralization. However, excessive SHMs may deviate from the trajectory of broad neutralization. This study provides a strategy to uncover bnAbs against highly mutable pathogens and the cross-serotype antigenic structures to explore broadly protective FMDV vaccine. The scarcity of broadly neutralizing antibodies (bnAbs) in the body significantly hinders their discovery and elucidation of the conserved antigenic structure of highly mutable pathogens. Foot-and-mouth disease virus (FMDV) severely infects pigs and exists as seven distinct serotypes without cross-protection. In this study, we present a strategy for rapid discovery of cross-serotype bnAbs by constructing of specific B-cell repertoires and exploring of common clonotypes. We originally isolated porcine bnAbs against FMDV serotypes O, A and/or Asia1, and proved for the first time that receptor binding region in VP1 can induce the production of cross-serotype bnAbs. The evolution of cross-serotype bnAbs reveals how somatic hypermutations balance the breadth and potency of neutralization. FMDV bnAbs employ dual neutralization mechanisms to neutralize viruses via receptor mimicry and destabilizing the viral particles. This study provides valuable guidelines that facilitate the isolation of bnAbs against the highly variable viruses and aid in designing a universal FMDV vaccine.

Prokaryotic Expression of Ligand Binding Domain of Porcine Integrin Β8 As FMDV Receptor and Preparation of Its Polyclonal Antibody

Induction of Partial Protection against Foot and Mouth Disease Virus in Guinea Pigs by Neutralization with the Integrin β6-1 Subunit

Prokaryotic Expression of Structural Protein VP1 of Foot-and-mouth disease virus Type O and Analysis of Its Antigenicity

[Cloning, Expression and Preparation of Polyclonal Antibody for IBDV Non-Structure Protein Gene].

Expression and immunogenicity of recombinant fusion protein comprising foot-and-mouth disease virus structural protein VP1 and intercellular adhesion molecule ICAM-2

Immunogenicity analysis of the E. coli expressed structural protein VP1 of persistent infection foot-and-mouth disease virus

Prokaryotic Expression and Activity Analysis of VP1 of Foot-and-Mouth Disease Virus Serotype A

Detection of Foot-and-mouth Virus Antibodies Using a Purified Protein from the High-Level Expression of Codon-Optimized, Foot-and-mouth Disease Virus Complex Epitopes in Escherichia Coli.

Development of an Indirect ELISA Based on VP1-CRT Fusion Protein for Detection of FMDV-O in Swine

Isolation and Characterization of Porcine Monoclonal Antibodies Revealed Two Distinct Serotype-Independent Epitopes on VP2 of Foot-and-mouth Disease Virus.

Prokaryotic Expression and Activity Analysis of VP1 Gene of Foot-and-Mouth Disease Virus Serotype O

Prokaryotic expression of structural domains of the Newcastle disease virus fusion protein and analyses of their antigenic epitopes

B cell epitopes within VP1 of type O foot-and-mouth disease virus for detection of viral antibodies

Engineered Recombinant Escherichia Coli Probiotic Strains Integrated with F4 and F18 Fimbriae Cluster Genes in the Chromosome and Their Assessment of Immunogenic Efficacy in Vivo.

High-level expression of codon optimized foot-and-mouth disease virus complex epitopes and cholera toxin B subunit chimera in Hansenula polymorpha.

Expression and Application of the Recombinant Non-Structural Proteins of FMDV

Expression,Purification and Identification of 3D Protein N Terminal T Cell Epitope Recombinant Protein of Foot and Mouth Disease Virus

Recombinant Expression and Activity Identification of 3D Protein C Terminal Th Epitope Peptides of Foot and Mouth Disease Virus

Preparation and characterization of a single-domain antibody specific for the porcine epidemic diarrhea virus spike protein

Discovery, recognized antigenic structures, and evolution of cross-serotype broadly neutralizing antibodies from porcine B-cell repertoires against foot-and-mouth disease virus

Expression and Immunogenicity of Two Recombinant Fusion Proteins Comprising Foot-and-Mouth Disease Virus Structural Protein VP1 and DC-SIGN-Binding Glycoproteins